Keyphrases
Epoxyeicosatrienoic Acids
95%
14,15-epoxyeicosatrienoic Acid
48%
Soluble Epoxide Hydrolase
46%
Arachidonic Acid
44%
Dihydroxyeicosatrienoic Acid
41%
Cyclooxygenase-2
40%
Acid Metabolism
40%
Endothelial Cells
36%
Alzheimer's Disease
30%
20-hydroxyeicosatetraenoic Acid (20-HETE)
28%
Peroxisome Proliferator-activated Receptor
25%
Vasoactive Intestinal Peptide
24%
Prostaglandin E2
24%
Phospholipids
23%
Porcine Coronary Artery
22%
Smooth muscle Cells
21%
Vascular Smooth muscle Cells
20%
Overexpression
20%
Arterial Smooth muscle
18%
Human Bronchial Epithelial Cells
18%
TREM-1
18%
Cerebral Endothelial Cell
18%
Wound Healing
18%
Pulmonary Epithelial Cells
18%
Soluble Epoxide Hydrolase Inhibitor
17%
Epoxy
16%
11,12-Epoxyeicosatrienoic Acid
15%
Cerebral Microcirculation
14%
Interleukin-1β
14%
Lipopolysaccharide-induced
14%
Miller Fisher Syndrome
14%
Induced Expression
13%
Rickettsia
13%
Diols
12%
Human Catalase
12%
TRNA-derived Fragments
12%
Acute Lung Injury
12%
Mitochondrial Transcription Factor A
12%
Human Brain Microvascular Endothelial Cells (HBMEC)
12%
Rickettsial Infection
12%
Anandamide
12%
Insulin Resistance
12%
Phosphatidylcholine
12%
Incubation
12%
Cellular Lipids
11%
Barrier Dysfunction
11%
Vascular Endothelial Cells
11%
Chronic Obstructive Pulmonary Disease
11%
Coronary Artery Endothelial Cells
10%
Porcine
10%
Pharmacology, Toxicology and Pharmaceutical Science
Epoxyicosatrienoic Acid
100%
Epoxide Hydrolase
55%
14,15 Epoxy 5,8,11 Icosatrienoic Acid
47%
Arachidonic Acid
41%
Pig
30%
Phospholipid
28%
Cytochrome P450
26%
Peroxisome Proliferator Activated Receptor
24%
20 Hydroxyicosatetraenoic Acid
22%
Cyclooxygenase 2
19%
Hydrolase Inhibitor
18%
Vasoactive Intestinal Polypeptide
18%
Wound Healing
18%
Multiple Sclerosis
18%
Prostaglandin E2
16%
Messenger RNA
16%
Egg Lecithin
15%
Alzheimer's Disease
12%
Infection
11%
Fatty Acid
11%
Calcium Ion
9%
Inflammation
9%
Bradykinin
9%
Neurologic Disease
8%
Epoxide
8%
Bleomycin
7%
Disease
7%
Unspecific Monooxygenase
7%
Binding Protein
6%
Alcohol Dehydrogenase
6%
Cardiovascular Disease
6%
Prostaglandin
6%
Normal Human
6%
Atorvastatin
6%
Triggering Receptor Expressed on Myeloid Cells 1
6%
Protein ZO1
6%
Membrane Phospholipid
6%
Mitochondrial Transcription Factor A
6%
Insulin Resistance
6%
Ginkgolide B
6%
Virus Infection
6%
Immunotherapy
6%
Myocardial Ischemia Reperfusion Injury
6%
Hydration
6%
Fibromyalgia
6%
Bleomycin-Induced Pulmonary Fibrosis
6%
Prostaglandin Synthase
6%
Adverse Event
6%
Phosphatase
6%
Rickettsiosis
6%